SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Coronavirus - Covid 19 Information Sharing Forum
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: w0z10/15/2024 7:57:54 AM
6 Recommendations

Recommended By
GPL
Hugh Bett
Jerry Held
maceng2
Thomas M.

and 1 more member

   of 5933
 
10 Shocking Stories the Media Buried Today

#10 - [url=https://x.com/VigilantFox/status/1845968270316249190]Cancer Researcher Drops Ivermectin Bombshell[/url]

The first peer-reviewed protocol using Ivermectin and Fenbendazole for cancer treatment has finally been peer-reviewed and published. This is huge. Dr. Makis says he is already seeing “incredible successes with these repurposed drugs.” Here’s the quick summary of the study’s findings:

• Ivermectin targets cancer cells by disrupting their mitochondrial function, leading to cell death (apoptosis). It also blocks key energy pathways, showing significant tumor shrinkage, especially in pancreatic cancer.

• Fenbendazole and Mebendazole, both antiparasitic drugs, have been found to halt cancer cell growth, interfere with glucose metabolism, and trigger apoptosis. In some preclinical trials, these drugs have even outperformed standard chemotherapy in reducing tumor growth.

• Remarkably, three patients with stage IV genitourinary cancers were treated with high-dose Fenbendazole (1,000 mg, three times a week for several months) and experienced complete remission. This is remarkable and especially hopeful for patients who have tried everything else with no luck. The next step will be further clinical trials to validate the protocol's effectiveness among larger populations.

Follow @MakisMD for more updates on this matter.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News